Cancer Moonshot? – Funding Opportunities

The funding opportunity announcements (FOAs) listed below highlight research initiatives that align with the efforts of the Cancer Moonshot. They may be supported with existing funds or with the 21st Century Cures funding.

Planning for implementation of longer-term scientific initiatives is also underway. We will continue to update this page as new funding opportunities become available so check back often or sign up to receive automatic email updates on Cancer Moonshot-related activities.

More information about the recently announced funding opportunities is available on the Cancer Moonshot Funding Resources page.

Please note that all publications and data resulting from Cancer Moonshot funded initiatives will be required to be immediately accessible. For more information, see the Cancer Moonshot Public Access and Data Sharing Policy.

Open Funding Opportunity Announcements (FOA)
BRP Recommendation	Title	Announcement Number	Opening Date	Expiration Date
Prevention and Early Detection: Implementation Science	Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS): Coordinating Center (U24)	RFA-CA-17-039	12/18/2017	1/19/2018
Prevention and Early Detection: Implementation Science	Accelerating Colorectal Cancer Screening and follow-up through Implementation Science (ACCSIS)(UG3/UH3)	RFA-CA-17-038	12/18/2017	1/19/2018
Generation of Human Tumor Atlases	Human Tumor Atlas Network: Data Coordinating Center (U24)	RFA-CA-17-036	12/18/2017	1/19/2018
Generation of Human Tumor Atlases	Pre-Cancer Atlas (PCA) Research Centers (U2C)	RFA-CA-17-035	12/18/2017	1/19/2018
Generation of Human Tumor Atlases	Human Tumor Atlas Research Centers (U2C)	RFA-CA-17-034	12/18/2017	1/19/2018
Symptom Management Research	Analyzing and Interpreting Clinician and Patient Adverse Event Data to Better Understand Tolerability (U01)	RFA-CA-17-052	12/17/2017	1/18/2018
Symptom Management Research	Coordinating Center for Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (U24)	RFA-CA-17-043	12/17/2017	1/18/2018
Symptom Management Research	Research Centers for Improving Management of Symptoms During and Following Cancer Treatment (UM1)	RFA-CA-17-042	12/17/2017	1/18/2018
Cancer Immunotherapy Translational Science Network	Immuno-Oncology Translation Network (IOTN): Cellular Immunotherapy Data Resource (CIDR) (U24)	RFA-CA-17-048	12/16/2017	1/17/2018
Cancer Immunotherapy Translational Science Network	Immuno-Oncology Translation Network (IOTN): Data Management and Resource-Sharing Center (DMRC) (U24)	RFA-CA-17-047	12/16/2017	1/17/2018
Cancer Immunotherapy Translational Science Network	Immuno-Oncology Translation Network (IOTN): Cancer Immunoprevention Research Projects (U01)	RFA-CA-17-046	12/16/2017	1/17/2018
Cancer Immunotherapy Translational Science Network	Immuno-Oncology Translation Network (IOTN): Cancer Immunotherapy Research Projects (U01)	RFA-CA-17-045	12/16/2017	1/17/2018
Prevention and Early Detection: Implementation Science	Approaches to Identify and Care for Individuals with Inherited Cancer Syndromes (U01)	RFA-CA-17-041	12/9/2017	1/10/2018
Therapeutic Target Identification to Overcome Resistance	Mechanisms of Cancer Drug Resistance and Sensitivity: Coordinating Center (U24)	RFA-CA-17-044	12/5/2017	1/6/2018
Cancer Immunotherapy Translational Science Network	Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U01)	RFA-CA-17-051	11/19/2017	12/20/2017
Cancer Immunotherapy Translational Science Network	Pediatric Immunotherapy Discovery and Development Network (PI-DDN)(U54)	RFA-CA-17-050	11/19/2017	12/20/2017
Fusion Oncoproteins in Childhood Cancers	Fusion Oncoproteins in Childhood Cancers (FusOnC2) Consortium (U54)	RFA-CA-17-049	10/15/2017	11/16/2017
Cancer Immunotherapy Translational Science Network	Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01)	PAR-17-245	5/5/2017	5/8/2020
Cancer Immunotherapy Translational Science Network	Collaborative Research Projects to Enhance Applicability of Mammalian Models for Translational Research (Collaborative R01)	PAR-17-244	5/5/2017	5/8/2020
New Enabling Technologies	Activities to Promote Technology Research Collaborations (APTRC) for Cancer Research (Admin Supp)	PA-17-143	3/12/2017	12/13/2017
Fusion Oncoproteins in Childhood Cancers	Administrative Supplements to Promote Research Collaborations on Fusion Oncoproteins as Drivers of Childhood Cancer (Admin Supp)	PA-17-138	3/1/2017	3/29/2018
Fusion Oncoproteins in Childhood Cancers	Gene Fusions in Pediatric Sarcomas (R21)	PA-16-252	9/16/2016	5/8/2019
Cancer Immunotherapy Translational Science Network	Metabolic Reprogramming to Improve Immunotherapy (R21)	PAR-16-229	9/16/2016	9/8/2019
Prevention and Early Detection: Implementation Science	Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R01)	PAR-16-202	9/11/2016	6/14/2019
Prevention and Early Detection: Implementation Science	Improving Smoking Cessation in Socioeconomically Disadvantaged Populations via Scalable Interventions (R21)	PAR-16-201	9/11/2016	6/14/2019
Fusion Oncoproteins in Childhood Cancers	Gene Fusions in Pediatric Sarcomas (R01)	PA-16-251	9/5/2016	5/8/2019
Cancer Immunotherapy Translational Science Network	Metabolic Reprogramming to Improve Immunotherapy (R01)	PAR-16-228	9/5/2016	9/8/2019
Generation of Human Tumor Atlases	Emerging Questions in Cancer Systems Biology (U01)	PAR-16-131	5/24/2016	11/24/2018
Prevention and Early Detection: Implementation Science	Dissemination and Implementation Research in Health (R21)	PAR-16-236	5/16/2016	5/8/2019
Prevention and Early Detection: Implementation Science	Dissemination and Implementation Research in Health (R01)	PAR-16-238	5/10/2016	5/8/2019

Closed Funding Opportunity Announcements (FOA)
BRP Recommendation	Title	Announcement Number	Opening Date	Expiration Date
Cancer Immunotherapy Translational Science Network	Activities to Promote Research Collaborations on Immune-Related Adverse Events (APRC-irAEs) Associated with Cancer Immunotherapy (Admin Supp)	PA-17-248	5/15/2017	6/16/2017
Cancer Immunotherapy Translational Science Network	Canine Immunotherapy Trials and Correlative Studies (U01)	RFA-CA-17-001	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Coordinating Center for Canine Immunotherapy Trials and Correlative Studies (U24)	RFA-CA-17-002	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies on the Tumor Microenvironment (U01)	RFA-CA-17-015	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Resource Center for the Consortium for Pancreatic Ductal Adenocarcinoma (PDAC) Translational Studies (U24)	RFA-CA-17-016	2/7/2017	3/8/2017
Cancer Immunotherapy Translational Science Network	Cancer Immune Monitoring and Analysis Centers (CIMACs) (U24)	RFA-CA-17-005	2/17/2017	3/18/2017
Cancer Immunotherapy Translational Science Network	Cancer Immunologic Data Common (CIDC) (U24)	RFA-CA-17-006	2/17/2017	3/18/2017
Cancer Immunotherapy Translational Science Network	Development and Validation of Non-Mouse Reagents to Enable Preclinical Development of Novel Therapeutics (R43/44)	PHS2018-1/ Topic 372	7/18/2017	10/20/2017
Generation of Human Tumor Atlases	Imaging-Based Tools for Longitudinal and Multi-Dimensional Mapping of the Tumor and its Microenvironment(R43/R44)	PHS2018-1/ Topic 376	7/18/2017	10/20/2017
National Cancer Data Ecosystem	PDX Development and Trial Centers (PDTCs) (U54)	RFA-CA-17-003	2/3/2017	3/4/2017
National Cancer Data Ecosystem	PDX Data Commons and Coordinating Center (PDCCC) for the PDX Development and Trial Centers Research Network (PDXNet) (U24)	RFA-CA-17-004	2/3/2017	3/4/2017
New Enabling Technologies	Integration and Validation of Emerging Technologies to Accelerate Cancer Research (R33)	RFA-CA-17-023	4/10/2017	5/11/2017
New Enabling Technologies	Computer Aided Decision Support for Radiation Oncology (R43/R44)	PHS2018-1/ Topic 380	7/18/2017	10/20/2017
New Enabling Technologies	Diagnostic Imaging for Cancer Immunotherapies (R43/R44)	PHS2018-1/ Topic 375	7/18/2017	10/20/2017
New Enabling Technologies	Tools and Technologies for Monitoring RNA Modifications (R43)	PHS2018-1/ Topic 373	7/18/2017	10/20/2017
Symptom Management Research	Bridging the Guideline Implementation Gap: Clinical Decision-Support to Improve Cancer Symptom Management (R43/R44)	PHS2018-1/ Topic 377	7/18/2017	10/20/2017
Symptom Management Research	Software Enabling Data Integration from Wearable Sensors to Generate Novel Analytics for Cancer Patients (R43/R44	PHS2018-1/ Topic 379	7/18/2017	10/20/2017
Therapeutic Target Identification to Overcome Resistance	Mechanisms of Cancer Drug Resistance and Sensitivity (U54)	RFA-CA-17-009	2/3/2017	3/4/2017

Updated: October 30, 2017

This content is provided by the National Cancer Institute (www.cancer.gov)

Syndicated Content Details:
Source URL: https://www.cancer.gov/publishedcontent/syndication/1067782.htm
Source Agency: National Cancer Institute (NCI)
Captured Date: 2016-12-13 14:10:29.0